Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease

E-ISSN： 1996-3181|9|5|574-595

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.5, 2010-11, pp. : 574-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3470-3526

Bentham Science Publishers

Access to resources Recommend Favorite

Group I Metabotropic Glutamate Receptor Interacting Proteins: Fine-Tuning Receptor Functions in Health and Disease

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 494-503

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Group I Metabotropic Glutamate Receptors mGlu1 and mGlu5 in Nociceptive Signalling

Current Neuropharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 363-393

Bentham Science Publishers

Access to resources Recommend Favorite

Different effects of NMDA/group I metabotropic glutamate receptor agents in - and -opioid receptor agonist-induced supraspinal antinociception

By Suzuki T. Aoki T. Ohnishi O. Nagase H. Narita M.

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite

Involvement of a cyclic-AMP pathway in group I metabotropic glutamate receptor responses in neonatal rat cortex

By Schaffhauser H. de Barry J. Muller H. Heitz M.-P. Gombos G. Mutel V.

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 289-297

Elsevier

Access to resources Recommend Favorite